TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 150 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,421,085 | +133.7% | 1,263,721 | +118.5% | 1.82% | +151.8% |
| Q4 2022 | $12,160,976 | +25.0% | 578,268 | +46.5% | 0.72% | +27.6% |
| Q3 2022 | $9,725,000 | +88.8% | 394,678 | +85.6% | 0.57% | +31.9% |
| Q2 2022 | $5,151,000 | -69.6% | 212,593 | -67.7% | 0.43% | -66.7% |
| Q1 2022 | $16,963,000 | -47.5% | 658,249 | -36.8% | 1.29% | -31.8% |
| Q4 2021 | $32,308,000 | +204.7% | 1,040,858 | +138.0% | 1.89% | +200.5% |
| Q3 2021 | $10,604,000 | – | 437,280 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 875,221 | $19,683,720 | 7.52% |
| Deep Track Capital, LP | 6,147,268 | $138,252,057 | 5.68% |
| Kynam Capital Management, LP | 1,563,595 | $35,165,252 | 4.54% |
| GREAT POINT PARTNERS LLC | 1,003,000 | $22,557,470 | 4.43% |
| ARMISTICE CAPITAL, LLC | 7,148,000 | $160,758,520 | 2.32% |
| HighVista Strategies LLC | 121,834 | $2,740,047 | 2.23% |
| MPM BioImpact LLC | 313,642 | $7,053,809 | 1.83% |
| Sofinnova Investments, Inc. | 1,263,721 | $28,421,085 | 1.82% |
| Octagon Capital Advisors LP | 495,000 | $11,132,550 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 358,613 | $8,065,206 | 1.55% |